NASDAQ:VNDA

Vanda Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy VNDA

*Your capital is at risk

$6.09

-0.0400 (-0.653%)

At Close: Jun 03, 2026

Future Pak raises cash portion of buyout offer for Vanda

08:36am, Thursday, 13'th Jun 2024

Contract manufacturer Future Pak said on Thursday it has raised the cash portion of its buyout offer as part of a final attempt to acquire Vanda Pharmaceuticals.

Future Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.

08:15am, Thursday, 13'th Jun 2024

WIXOM, Mich.--(BUSINESS WIRE)--Future Pak, LLC and its affiliates ("Future Pak") today announced that it has submitted a final attempt to engage with Vanda Pharmaceuticals Inc. ("Vanda" or the "Compan

CIONIC Unveils Three New Centers of Excellence on the East Coast to Aid Patient Mobility Through the Use of FDA-Cleared Bionic Clothing and Neuromodulation

08:17am, Monday, 10'th Jun 2024

SAN FRANCISCO--(BUSINESS WIRE)-- #assistivetechnology--CIONIC Unveils Three New Centers of Excellence to Aid Patient Mobility Through the Use of FDA-Cleared Bionic Clothing and Neuromodulation.

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

08:14am, Monday, 10'th Jun 2024

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) concerning the Company and its directors' and officers' poss

Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?

07:06am, Friday, 07'th Jun 2024

Vanda (VNDA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.

09:24am, Thursday, 06'th Jun 2024

No Shareholder Action Required at This Time WASHINGTON , June 6, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it has received an unsol

Cycle Pharmaceuticals Announces All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

08:00am, Thursday, 06'th Jun 2024

BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Cycle Pharmaceuticals Ltd (“Cycle” or the “Company”), a rapidly growing pharmaceutical company focused on treatments for the underserved rare dise

Vanda Insights: Aramco share sale is not surprising

06:00am, Friday, 31'st May 2024

Vandana Hari, founder of Vanda Insights, says it'll be a "test of investor appetite."

Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference

05:20pm, Thursday, 30'th May 2024

WASHINGTON , May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies 2024 Global Healthcare Conference in New

Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®

04:48pm, Thursday, 30'th May 2024

WASHINGTON , May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that ownership of the U.S. New Drug Application and Investigational New Drug Applications fo

Vanda Pharmaceuticals Announces Presentations at SLEEP 2024

02:17pm, Wednesday, 29'th May 2024

WASHINGTON , May 29, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2024, to be held in Houston, TX from June 1 through June 5, 2024. The

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders

04:46pm, Friday, 24'th May 2024

WASHINGTON , May 24, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Company's Board of Directors (the "Board") carefully reviewed the revised unsolicit

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by